Mr Maguire has over 30 years of global life sciences and healthcare investment banking, management and board experience, raising well in excess of $1billion as an executive and an advisor. Mr Maguire has set up three companies and two divisions of large cap companies.  Having recently been Chairman and CEO of Xenetic Biosciences Inc (XBIO), Scott turned a life science start up with a few patents into a clinical stage company listed on NASDAQ, a listing he led in 2016. He is also co-founder and board member of Renal Services UK Ltd, one of largest providers of dialysis services in the UK. In 2001 he founded Healthcare Capital Partners Ltd, a healthcare and life science corporate finance and proprietary investment boutique which has been responsible for hundreds of millions in investments and exits since its founding. In 1996 he co-founded the Arthur Andersen global healthcare corporate finance practice based in London which he assisted in building from 2 to 35 bankers globally. Scott started his banking career on Wall Street with Merrill Lynch in 1987.